Results 171 to 180 of about 1,731,278 (307)

Pyroptosis‐Inducing Engineered Microparticles for Cancer Immunotherapy

open access: yesAdvanced Science, Volume 13, Issue 31, 4 June 2026.
Engineered microparticles co‐delivering geldanamycin and dual nanobodies induce targeted pyroptosis and block PD‐L1 and CD47 pathways, reprogramming the tumor microenvironment and achieving potent antitumor immunity in lung cancer models with minimal toxicity.
Tianli Hao   +12 more
wiley   +1 more source

Integrating Oncolytic Virus Engineering and Delivery Strategies for Enhanced Cancer Virotherapy

open access: yesAggregate, Volume 7, Issue 6, June 2026.
Integrated engineering strategies combining oncolytic virus (OV) design with advanced delivery platforms overcome biological barriers and enhance cancer virotherapy. Genetic engineering improves viral potency and selectivity, while local and systemic delivery systems promote viral protection, tumor targeting, penetration, and tumor microenvironment ...
Jiliang Zhao   +5 more
wiley   +1 more source

Relationships Among Maternal Epstein–Barr Virus Antibodies, COVID‐19, and Stress in Mothers up to 1‐Year Postpartum

open access: yesAmerican Journal of Human Biology, Volume 38, Issue 6, June 2026.
ABSTRACT Objectives Both psychosocial stress and current infection can increase the likelihood of reactivation of latent Epstein–Barr virus (EBV). Pregnancy and infection with SARS‐CoV‐2 can be stressful and modulate immune function. However, it is unknown how SARS‐CoV‐2 infection and stress further interact among postpartum women to affect EBV antigen
Emma Anastasi   +18 more
wiley   +1 more source

Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins. [PDF]

open access: yesDiscov Oncol
Al-Khreisat MJ   +8 more
europepmc   +1 more source

Limited Role of Lipopolysaccharide Lewis Antigens in Adherence of Helicobacter pylori to the Human Gastric Epithelium

open access: yesInfection and Immunity, 2003
J. Mahdavi   +3 more
semanticscholar   +1 more source

Channel Dysfunction as the Basis for Comorbidities in Multiple Sclerosis and Depression

open access: yesArchiv der Pharmazie, Volume 359, Issue 6, June 2026.
Ion channel remodelling induced by neuroinflammation in multiple sclerosis alters neuronal excitability and immune signalling, creating shared molecular pathways that link multiple sclerosis pathology to depression and reveal novel pharmacological targets.
Nicole Rychlik   +4 more
wiley   +1 more source

Subunit vaccination using Atomic Layering Thermostable Antigen and Adjuvant (ALTA<sup>®</sup>) platform elicits enhanced humoral and cellular immune responses. [PDF]

open access: yesFront Immunol
Ivanova DL   +12 more
europepmc   +1 more source

Multi‐omics analysis identifies a major histocompatibility complex class II‐associated antigen‐presenting cancer‐associated fibroblast‐like state linked to the nuclear factor erythroid 2‐related factor 2‐karyopherin subunit beta 1 axis in nonsmall cell lung cancer

open access: yesJournal of Cell Communication and Signaling, Volume 20, Issue 2, June 2026.
NSCLC contains an MHC‐II‐associated antigen‐presenting CAF‐like (apCAF‐like) state regulated by the NRF2‐KPNB1 axis. NRF2/KPNB1 signaling suppresses CIITA‐dependent antigen presentation and T‐cell activation, whereas inhibition of this pathway enhances antitumor immunity and improves responsiveness to anti‐PD‐1 therapy.
Fei Zheng   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy